By Drug Target Review –
Discover how Immorta Bio’s cellular therapies are addressing cancer and liver failure, with the potential to transform healthcare.
Recent years have witnessed remarkable advancements in cellular therapies, particularly in the development of treatments that harness the power of stem cells and the immune system. At the forefront of these innovations is Dr Thomas Ichim, a distinguished expert in biotechnology and stem cell therapy at Immorta Bio. With an extensive background in these fields, Ichim is dedicated to advancing personalised cellular therapies aimed at addressing age-related diseases, with a special focus on cancer and liver failure.
